These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 23777224

  • 1. Risk of all-cause hospitalization in COPD patients initiating long-acting or short-acting beta agonist therapy.
    Bollu V, Ejzykowicz F, Rajagopalan K, Karafilidis J, Hay JW.
    J Med Econ; 2013 Aug; 16(8):1082-8. PubMed ID: 23777224
    [Abstract] [Full Text] [Related]

  • 2. Inhaled corticosteroids are more effective in COPD patients when used with LABA than with SABA.
    Kiri VA, Bettoncelli G, Testi R, Viegi G.
    Respir Med; 2005 Sep; 99(9):1115-24. PubMed ID: 15921904
    [Abstract] [Full Text] [Related]

  • 3. Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators.
    Keshishian A, Xie L, Dembek C, Yuce H.
    Clin Ther; 2019 Nov; 41(11):2283-2296. PubMed ID: 31630815
    [Abstract] [Full Text] [Related]

  • 4. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM, Culler SD, Ershoff D, Gutierrez B.
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [Abstract] [Full Text] [Related]

  • 5. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.
    Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists.
    Mapel DW, Hurley JS, Roblin D, Roberts M, Davis KJ, Schreiner R, Frost FJ.
    Respir Med; 2006 Apr; 100(4):595-609. PubMed ID: 16199151
    [Abstract] [Full Text] [Related]

  • 8. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
    Suh DC, Lau H, La HO, Choi IS, Geba GP.
    Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L, Blanchette CM, Qian J, Yang HW, Zhao L, Zuckerman IH, Pak GH, Silver H, Dalal AA.
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [Abstract] [Full Text] [Related]

  • 12. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
    Gershon AS, Campitelli MA, Croxford R, Stanbrook MB, To T, Upshur R, Stephenson AL, Stukel TA.
    JAMA; 2014 Sep 17; 312(11):1114-21. PubMed ID: 25226477
    [Abstract] [Full Text] [Related]

  • 13. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS, Wang L, To T, Luo J, Upshur RE.
    COPD; 2008 Aug 17; 5(4):229-34. PubMed ID: 18671148
    [Abstract] [Full Text] [Related]

  • 14. Exacerbations, health services utilization, and costs in commercially-insured COPD patients treated with nebulized long-acting β2-agonists.
    Chen YJ, Makin C, Bollu VK, Navaie M, Celli BR.
    J Med Econ; 2016 Aug 17; 19(1):11-20. PubMed ID: 26357881
    [Abstract] [Full Text] [Related]

  • 15. Trends and Factors Associated with Nebulized Therapy Prescription in Older Adults with Chronic Obstructive Pulmonary Disease from 2008 to 2015.
    Singh M, Duarte AG, Hsu ES, Kuo YF, Sharma G.
    J Aerosol Med Pulm Drug Deliv; 2020 Jun 17; 33(3):161-169. PubMed ID: 32017642
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
    Gershon A, Croxford R, To T, Stanbrook MB, Upshur R, Sanchez-Romeu P, Stukel T.
    Ann Intern Med; 2011 May 03; 154(9):583-92. PubMed ID: 21536937
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ.
    COPD; 2007 Jun 03; 4(2):127-34. PubMed ID: 17530506
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.